Takeda Pharmaceutical
TAK
#491
Rank
S$61.40 B
Marketcap
S$18.45
Share price
0.28%
Change (1 day)
2.45%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : S$6.48 Billion

According to Takeda Pharmaceutical's latest financial reports the company has S$6.48 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31S$3.63 B-13.67%
2024-03-31S$4.20 B-23.77%
2023-03-31S$5.52 B-43.26%
2022-03-31S$9.73 B-20.09%
2021-03-31S$12.17 B40.94%
2020-03-31S$8.64 B-2.36%
2019-03-31S$8.85 B91.26%
2018-03-31S$4.62 B-1.99%
2017-03-31S$4.72 B-29.67%
2016-03-31S$6.71 B-17.76%
2015-03-31S$8.16 B-21.33%
2014-03-31S$10.37 B40.3%
2013-03-31S$7.39 B5.9%
2012-03-31S$6.98 B-47.15%
2011-03-31S$13.21 B0.5%
2010-03-31S$13.14 B12.56%
2009-03-31S$11.68 B-48.58%
2008-03-31S$22.71 B-2.02%
2007-03-31S$23.18 B-10.22%
2006-03-31S$25.82 B10.15%
2005-03-31S$23.44 B10.48%
2004-03-31S$21.22 B24.03%
2003-03-31S$17.11 B39.41%
2002-03-31S$12.27 B18.35%
2001-03-31S$10.37 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$24.08 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$13.56 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
S$19.44 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.65 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
S$1.60 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.01 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
S$12.25 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$5.76 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$23.63 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA